10x Genomics, Inc. (TXG) Revenue Growth
10x Genomics, Inc. (TXG) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2020-12-31 | 21.53% |
| 2021-12-31 | 64.13% |
| 2022-12-31 | 5.28% |
| 2023-12-31 | 19.81% |
| 2024-12-31 | -1.28% |
| 2025-12-31 | 5.25% |
How TXG compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | 8.72% |
| ACHC | Acadia Healthcare Company Inc. | 5.04% |
| ZTS | Zoetis Inc. Class A | 2.28% |
| BKD | Brookdale Senior Living Inc. | 2.19% |
| BIO | Bio-Rad Laboratories Inc. Class A | 0.65% |
These are five companies in the same sector as TXG with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get 10x Genomics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("TXG", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TXG | $61.67 | +0.04% | 0.89M |
| 3 | ||||
| 4 | ||||
| 5 |